Lupin Ltd announced that its unit has received US FDA approval for Imipramine Pamoate capsules, an abbreviated new drug application (ANDA). The capsules are the generic equivalent of Mallinckrodt’s Tofranil-PM. The capsules had sales of about USD 39 million in the year 2009 in the US market.
Like
Dislike
Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.
"Exciting news! Elets technomedia is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest insights!" Click here!
